NeurATRIS is pleased to announce that we will be participating to « Médecine Translationnelle au service de l’innovation Thérapeutique : Enjeux, Besoins et Opportunités » (13th June, Paris)
The goal of this day is to provide an overview of translational medicine platforms of key account (academic and pharmaceutical industries) in order to understand how they work, their needs and their roles in the value chain of discovery and development of therapeutic solutions.
This is a unique opportunity to hear P. HANTRAYE, NeurATRIS director, and learn more about NeurATRIS assets to work alongside in your translational projects in the Neuroscience field for the characterization of neurodegenerative diseases.
Do not hesitate to contact us to set up a meeting.
NeurATRIS